EUVIMEDEUVIMED entdecken
Crossref

Novel Immunotherapies for Neurodegenerative Diseases

Bob Harris

EU Research · 2024

DOI: 10.56181//izyf6136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EU Research, 2024. Verfasst von Bob Harris.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

What drives the progression of neurodegenerative diseases like ALS, Alzheimer’s, and MS? Unraveling the mechanisms of neuroinflammation is at the heart of Prof. Bob Harris’s research at the Karolinska Institutet. His team is pioneering new therapeutic approaches by targeting microglial activity and harnessing advanced stem cell techniques. Their goal is to transform treatment strategies for these debilitating conditions.

Zitieren

APA

Harris, B. (2024). Novel Immunotherapies for Neurodegenerative Diseases. EU Research. https://doi.org/10.56181//izyf6136

Vancouver

Harris B. Novel Immunotherapies for Neurodegenerative Diseases. EU Research. 2024. doi:10.56181//izyf6136

BibTeX
@article{Harris2024,
  author = {Harris, Bob},
  title = {Novel Immunotherapies for Neurodegenerative Diseases},
  journal = {EU Research},
  year = {2024},
  doi = {10.56181//izyf6136}
}
Kostenlos starten →